首页> 外文会议>International Symposium on Ocular Pharmacology and Therapeutics >Clinical Trials, Human Subject Research, and the Development of New Technology
【24h】

Clinical Trials, Human Subject Research, and the Development of New Technology

机译:临床试验,人类主题研究和新技术的发展

获取原文

摘要

Academic intuitions have been placed in an increasingly complex internal and external regulatory environment which impacts the conduct of all research. In order to insure compliance with internal policies a number of separate units have been created in academic institutions where formerly a department Chair or Faculty Dean would have been sufficient to guide the conduct of both clinical and research faculty. Diversity, ethics, conflict of interest, contractual obligations, human resources, animal protection, vivarium, Institutional Review Boards, research administration , patient HIPPA and subject privacy, NIH policy and procedure, FDA drug and device regulations are each associated with a laundry list of items which must be read, understood and are subject to current compliance and retrospective reviews and audit.
机译:学术直觉被置于越来越复杂的内部和外部监管环境中,影响了所有研究的行为。 为了确保遵守内部政策,已经在学术机构中创建了许多单独的单位,以前是部门主席或教师院长的院校将足以指导临床和研究教师的行为。 多样性,伦理,利益冲突,合同义务,人力资源,动物保护,Vivarium,机构审查委员会,研究管理,患者河马和主题隐私,NIH政策和程序,FDA药物和设备规则各自与洗衣名单相关联 必须阅读,理解并遵守当前合规性和回顾性评论和审核。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号